88 results
Page 2 of 5
8-K
EX-1.1
tje04v6leffb4pg1
27 Jul 23
NeuroOne Medical Technologies Corporation Announces Proposed Public Offering of Common Stock
4:02pm
424B5
weteku0 8k2hf
26 Jul 23
Prospectus supplement for primary offering
4:24pm
424B5
ilxz2lomj7pc 8org
24 Jul 23
Prospectus supplement for primary offering
4:43pm
8-K
EX-99.1
wpq4gyvv
11 May 23
NeuroOne® Reports Second Quarter Fiscal Year 2023 Financial Results and Provides Corporate Update
4:16pm
8-K
EX-99.1
lxfphjaq
22 Dec 22
NeuroOne® Reports Fiscal Fourth Quarter and Full Fiscal Year 2022 Financial Results
9:11am
424B5
8wab p4tle0aqmqey
22 Dec 22
Prospectus supplement for primary offering
6:43am
8-K
EX-99.1
v1t0s15qbucam
25 Oct 22
NeuroOne® Receives FDA 510(k) Clearance to Market its Evo® sEEG System for Less than 30 Day Use
9:19am
8-K
EX-99.1
8m0ohiswjwv4a8 4e
14 Sep 22
Regulation FD Disclosure
8:30am
8-K
EX-99.1
bvjocywcth8
11 Aug 22
NeuroOne® Reports Third Quarter Fiscal Year 2022 Financial Results and Provides Corporate Update
4:49pm
8-K
EX-99.1
wmn dte3r91wxp34
3 Aug 22
NeuroOne® Announces $3.5 Million Accelerated Milestone Payment from Zimmer Biomet for Evo® sEEG Electrode
9:34am
8-K
EX-99.1
trtxr5zyzuxs1b8b
2 Jun 22
NeuroOne® Issues Letter to Stockholders in Connection With 2022 Annual Meeting of Stockholders
4:05pm
8-K
EX-99.1
4gck78tbc qw
16 May 22
NeuroOne Provides Evo® sEEG Update
4:38pm
8-K
EX-99.1
1nq fqlqe9a
12 May 22
NeuroOne Reports Second Quarter Fiscal Year 2022 Financial Results and Provides Corporate Update
4:17pm